Maxim Group We maintain our Buy rating on Applied DNA Sciences and price target of $6. Our target still implies 166% upside to Applied DNA’s (APDN) current share price and represents a valuation of seven ...
- Zacks Small Cap Research•2 days ago
On December 6, Applied DNA Sciences (APDN) announced financial results for the fiscal fourth quarter ended September 30, 2016. Total revenue for the fiscal fourth quarter of 2016 was $1.64 million, compared to $3.98 million for the same period of 2015, a decrease of 59%. During the conference call, management indicated that the year-over-year decrease in revenue resulted primarily from decreased sales to the textile industry for the securing of global cotton supply chains and reduced revenues from two non-recurring government commercialization contract awards that were completed in the fourth quarter of fiscal 2016.
- Marketwired•2 days ago
Applied DNA Sciences, Inc. , a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, is continuing its quest to...
APDN : Summary for Applied DNA Sciences Inc - Yahoo Finance
Applied DNA Sciences, Inc. (APDN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.10 x 800|
|Ask||2.20 x 7200|
|Day's Range||2.10 - 2.20|
|52 Week Range||1.76 - 4.26|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.83|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|